SCHEMBL2470132

SCHEMBL2470132

C=CCNCCc1ccc(N(C)S(=O)(=O)c2ccc(C(C)C)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
HPGD P15428 1/20 0.44
CNR2 P34972 7/20 0.42
CNR1 P21554 4/20 0.42
MCHR1 Q99705 1/20 0.42
MCOLN3 Q8TDD5 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MAPT P10636 2/20 0.41
LMNA P02545 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA4 P22748 1/20 0.41
CA9 Q16790 1/20 0.41
ADRB3 P13945 1/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4922303 0.99 ALDH1A1 (0.43) ALDH1A1HPGDCNR2CNR1MCHR1
SCHEMBL2470396 0.86 CNR2 (0.49) ALDH1A1CNR2CNR1MAPTCA12
Hydrochloric Acid SCHEMBL4922430 0.85 POLB (0.48) ALDH1A1CNR2CNR1MAPTCA12
SCHEMBL1718081 0.81 DRD3 (0.42) ALDH1A1SMN1; SMN2MAPTLMNACA12
SCHEMBL2470902 0.81 HDAC3 (0.49) ALDH1A1HPGDCNR2MCHR1MCOLN3
Hydrochloric Acid SCHEMBL4922945 0.80 DRD3 (0.42) ALDH1A1SMN1; SMN2MAPTLMNACA12
Hydrochloric Acid SCHEMBL4923250 0.80 HDAC3 (0.48) ALDH1A1HPGDCNR2MCHR1MCOLN3
SCHEMBL2470496 0.79 ADRB2 (0.57) ALDH1A1SMN1; SMN2MAPTLMNAADRB3
Hydrochloric Acid SCHEMBL4915819 0.78 ADRB2 (0.56) ALDH1A1SMN1; SMN2MAPTLMNAADRB3
SCHEMBL2472844 0.76 CNR2 (0.47) ALDH1A1CNR2CNR1MCOLN3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2371814-A1 Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor Abbott GmbH & Co. KG (DE) 2011-10-05 EP disclosed
EP-1809597-A1 AMINOETHYLAROMATIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR Abbott GmbH & Co. KG (DE) 2007-07-25 EP disclosed
WO-2006040179-A1 AMINOETHYLAROMATIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR ABBOTT GMBH & CO. KG (DE) 2006-04-20 WO disclosed